{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T04:27:44Z","timestamp":1764563264922,"version":"3.46.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"DOI":"10.1007\/s10585-025-10379-6","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:11:37Z","timestamp":1760674297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative stereotactic radiotherapy for brain metastases: results from a single-center retrospective analysis"],"prefix":"10.1007","volume":"42","author":[{"given":"E. K. M.","family":"Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. K. C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. H. F.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. B. T.","family":"Taw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. F.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. C. W.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. M. F.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S. C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. P.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Y.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. K.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"11","key":"10379_CR1","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","volume":"19","author":"DN Cagney","year":"2017","unstructured":"Cagney DN, Martin AM, Catalano PJ et al (2017) Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol 19(11):1511\u20131521. https:\/\/doi.org\/10.1093\/neuonc\/nox077","journal-title":"Neuro Oncol"},{"issue":"8","key":"10379_CR2","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/neuonc\/noz046","volume":"21","author":"R Kotecha","year":"2019","unstructured":"Kotecha R, Kim JM, Miller JA et al (2019) The impact of sequencing PD-1\/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastases. Neuro Oncol 21(8):1060\u20131068. https:\/\/doi.org\/10.1093\/neuonc\/noz046","journal-title":"Neuro Oncol"},{"key":"10379_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","volume":"322","author":"RA Patchell","year":"1990","unstructured":"Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494\u2013500. https:\/\/doi.org\/10.1056\/NEJM199002223220802","journal-title":"N Engl J Med"},{"issue":"2","key":"10379_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu UM et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29(2):134\u2013141. https:\/\/doi.org\/10.1200\/JCO.2010.30.1655","journal-title":"J Clin Oncol"},{"issue":"17","key":"10379_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","volume":"280","author":"RA Patchell","year":"1998","unstructured":"Patchell RA, Tibbs PA, Regine WF et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280(17):1485\u20131489. https:\/\/doi.org\/10.1001\/jama.280.17.1485","journal-title":"JAMA"},{"key":"10379_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/jamaoncol.2015.1142","volume":"1","author":"H Aoyama","year":"2015","unstructured":"Aoyama H, Tago M, Shirato H et al (2015) Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: secondary analysis of the JROSG 99\u20131 randomized clinical trial. JAMA Oncol 1:457\u2013464. https:\/\/doi.org\/10.1001\/jamaoncol.2015.1142","journal-title":"JAMA Oncol"},{"key":"10379_CR7","doi-asserted-by":"publisher","unstructured":"Brown PD, Jaeckle K, Ballman KV et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial [published correction appears in JAMA. 2018 Aug 7;320(5):510.]. JAMA 316(4):401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","DOI":"10.1001\/jama.2016.9839"},{"issue":"6","key":"10379_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000330387","volume":"89","author":"JC Rwigema","year":"2011","unstructured":"Rwigema JC, Wegner RE, Mintz AH et al (2011) Stereotactic radiosurgery to the resection cavity of brain metastases: a retrospective analysis and literature review. Stereotact Funct Neurosurg 89(6):329\u2013337. https:\/\/doi.org\/10.1159\/000330387","journal-title":"Stereotact Funct Neurosurg"},{"issue":"8","key":"10379_CR9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomized, controlled, phase 3 trial. Lancet Oncol 18(8):1040\u20131048. https:\/\/doi.org\/10.1016\/S1470-2045(17)30414-X","journal-title":"Lancet Oncol"},{"issue":"8","key":"10379_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","volume":"18","author":"PD Brown","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","journal-title":"Lancet Oncol"},{"issue":"6","key":"10379_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7785\/tcrt.2012.500410","volume":"12","author":"A Al-Omair","year":"2013","unstructured":"Al-Omair A, Soliman H, Xu W et al (2013) Hypofractionated stereotactic radiotherapy in five daily fractions for post-operative surgical cavities in brain metastases patients with and without prior whole brain radiation. Technol Cancer Res Treat 12(6):493\u2013499. https:\/\/doi.org\/10.7785\/tcrt.2012.500410","journal-title":"Technol Cancer Res Treat"},{"issue":"5","key":"10379_CR12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/s0360-3016(99)00549-0","volume":"46","author":"E Weltman","year":"2000","unstructured":"Weltman E, Salvajoli JV, Brandt RA et al (2000) Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 46(5):1155\u20131161. https:\/\/doi.org\/10.1016\/s0360-3016(99)00549-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10379_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","volume":"70","author":"PW Sperduto","year":"2008","unstructured":"Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70(2):510\u2013514. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.06.074","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10379_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijrobp.2022.03.020","volume":"114","author":"PW Sperduto","year":"2022","unstructured":"Sperduto PW, De B, Li J et al (2022) Graded prognostic assessment (GPA) for patients with lung cancer and brain metastases: initial report of the small cell lung cancer GPA and update of the non-small cell lung cancer GPA including the effect of programmed death ligand 1 and other prognostic factors. Int J Radiat Oncol Biol Phys 114(1):60\u201374. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.03.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10379_CR15","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/neuonc\/noy099","volume":"20","author":"PW Sperduto","year":"2018","unstructured":"Sperduto PW, Deegan BJ, Li J et al (2018) Estimating survival for renal cell carcinoma patients with brain metastases: an update of the renal graded prognostic assessment tool. Neuro Oncol 20(12):1652\u20131660. https:\/\/doi.org\/10.1093\/neuonc\/noy099","journal-title":"Neuro Oncol"},{"key":"10379_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ctro.2019.06.007","volume":"18","author":"PW Sperduto","year":"2019","unstructured":"Sperduto PW, Fang P, Li J et al (2019) Estimating survival in patients with gastrointestinal cancers and brain metastases: an update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA). Clin Transl Radiat Oncol 18:39\u201345. https:\/\/doi.org\/10.1016\/j.ctro.2019.06.007","journal-title":"Clin Transl Radiat Oncol"},{"issue":"2","key":"10379_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijrobp.2020.01.051","volume":"107","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J et al (2020) Beyond an updated graded prognostic assessment (Breast GPA): a prognostic index and trends in treatment and survival in breast cancer brain metastases from 1985 to today. Int J Radiat Oncol Biol Phys 107(2):334\u2013343. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.01.051","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"10379_CR18","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1200\/JCO-24-01351","volume":"43","author":"PW Sperduto","year":"2025","unstructured":"Sperduto PW, Marqueen KE, Chang E et al (2025) Improved survival and prognostication in melanoma patients with brain metastases: an update of the melanoma graded prognostic assessment. J Clin Oncol 43(16):1910\u20131919. https:\/\/doi.org\/10.1200\/JCO-24-01351","journal-title":"J Clin Oncol"},{"issue":"6","key":"10379_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s0305-7372(03)00105-1","volume":"29","author":"RA Patchell","year":"2003","unstructured":"Patchell RA (2003) The management of brain metastases. Cancer Treat Rev 29(6):533\u2013540. https:\/\/doi.org\/10.1016\/s0305-7372(03)00105-1","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"10379_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.seminoncol.2004.07.012","volume":"31","author":"KA Bradley","year":"2004","unstructured":"Bradley KA, Mehta MP (2004) Management of brain metastases. Semin Oncol 31(5):693\u2013701. https:\/\/doi.org\/10.1053\/j.seminoncol.2004.07.012","journal-title":"Semin Oncol"},{"issue":"3","key":"10379_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s0360-3016(98)00447-7","volume":"43","author":"PK Sneed","year":"1999","unstructured":"Sneed PK, Lamborn KR, Forstner JM et al (1999) Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43(3):549\u2013558. https:\/\/doi.org\/10.1016\/s0360-3016(98)00447-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10379_CR22","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/0360-3016(86)90288-9","volume":"12","author":"S Egawa","year":"1986","unstructured":"Egawa S, Tukiyama I, Akine Y et al (1986) Radiotherapy of brain metastases. Int J Radiat Oncol Biol Phys 12(9):1621\u20131625. https:\/\/doi.org\/10.1016\/0360-3016(86)90288-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10379_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jpainsymman.2005.02.009","volume":"30","author":"E Chow","year":"2005","unstructured":"Chow E, Davis L, Holden L, Tsao M, Danjoux C (2005) Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manag 30(1):18\u201323. https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.02.009","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"10379_CR24","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ijrobp.2008.12.013","volume":"75","author":"J Wong","year":"2009","unstructured":"Wong J, Hird A, Zhang L et al (2009) Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy. Int J Radiat Oncol Biol Phys 75(4):1125\u20131131. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.12.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10379_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/01.coc.0000143016.15783.5b","volume":"28","author":"D Kondziolka","year":"2005","unstructured":"Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2005) Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients\u2019 perspective regarding complications. Am J Clin Oncol 28(2):173\u2013179. https:\/\/doi.org\/10.1097\/01.coc.0000143016.15783.5b","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10379_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/s0360-3016(02)02770-0","volume":"53","author":"PK Sneed","year":"2002","unstructured":"Sneed PK, Suh JH, Goetsch SJ et al (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53(3):519\u2013526. https:\/\/doi.org\/10.1016\/s0360-3016(02)02770-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10379_CR27","doi-asserted-by":"publisher","first-page":"CD006121","DOI":"10.1002\/14651858.CD006121.pub4","volume":"9","author":"CG Patil","year":"2017","unstructured":"Patil CG, Pricola K, Sarmiento JM, Garg SK, Bryant A, Black KL (2017) Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev 9(9):CD006121. https:\/\/doi.org\/10.1002\/14651858.CD006121.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10379_CR28","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1227\/01.neu.0000064569.18914.de","volume":"52","author":"T Hasegawa","year":"2003","unstructured":"Hasegawa T, Kondziolka D, Flickinger JC, Germanwala A, Lunsford LD (2003) Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 52(6):1318\u20131326. https:\/\/doi.org\/10.1227\/01.neu.0000064569.18914.de","journal-title":"Neurosurgery"},{"issue":"5","key":"10379_CR29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.ijrobp.2017.08.014","volume":"99","author":"A Keller","year":"2017","unstructured":"Keller A, Dor\u00e9 M, Cebula H et al (2017) Hypofractionated stereotactic radiation therapy to the resection bed for intracranial metastases. Int J Radiat Oncol Biol Phys 99(5):1179\u20131189. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.08.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10379_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ijrobp.2019.11.022","volume":"106","author":"S Shi","year":"2020","unstructured":"Shi S, Sandhu N, Jin MC et al (2020) Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities. Int J Radiat Oncol Biol Phys 106(4):764\u2013771. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.11.022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10379_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1227\/NEU.0b013e31827fcd60","volume":"72","author":"JH Gans","year":"2013","unstructured":"Gans JH, Raper DM, Shah AH et al (2013) The role of radiosurgery to the tumor bed after resection of brain metastases. Neurosurgery 72(3):317\u2013326. https:\/\/doi.org\/10.1227\/NEU.0b013e31827fcd60","journal-title":"Neurosurgery"},{"key":"10379_CR32","doi-asserted-by":"publisher","unstructured":"Eitz KA, Lo SS, Soliman H et al (2020) Multi-institutional analysis of prognostic factors and outcomes after hypofractionated stereotactic radiotherapy to the resection cavity in patients with brain metastases [published correction appears in JAMA Oncol. 2020 Dec 1;6(12):1985. https:\/\/doi.org\/10.1001\/jamaoncol.2020.7078] [published correction appears in JAMA Oncol. 2024 Feb 1;10(2):261. https:\/\/doi.org\/10.1001\/jamaoncol.2023.6616]. JAMA Oncol 6(12):1901\u20131909. https:\/\/doi.org\/10.1001\/jamaoncol.2020.4630","DOI":"10.1001\/jamaoncol.2020.7078"},{"issue":"4","key":"10379_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ijrobp.2013.03.037","volume":"86","author":"G Minniti","year":"2013","unstructured":"Minniti G, Esposito V, Clarke E et al (2013) Multidose stereotactic radiosurgery (9 Gy \u00d7 3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys 86(4):623\u2013629. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.03.037","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10379_CR34","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1227\/NEU.0000000000000584","volume":"76","author":"DC Ling","year":"2015","unstructured":"Ling DC, Vargo JA, Wegner RE et al (2015) Postoperative stereotactic radiosurgery to the resection cavity for large brain metastases: clinical outcomes, predictors of intracranial failure, and implications for optimal patient selection. Neurosurgery 76(2):150\u2013157. https:\/\/doi.org\/10.1227\/NEU.0000000000000584","journal-title":"Neurosurgery"},{"issue":"6","key":"10379_CR35","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3171\/2010.11.JNS10939","volume":"114","author":"CA Jensen","year":"2011","unstructured":"Jensen CA, Chan MD, McCoy TP et al (2011) Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg 114(6):1585\u20131591. https:\/\/doi.org\/10.3171\/2010.11.JNS10939","journal-title":"J Neurosurg"},{"issue":"6","key":"10379_CR36","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1227\/NEU.0000000000000148","volume":"73","author":"N Luther","year":"2013","unstructured":"Luther N, Kondziolka D, Kano H et al (2013) Predicting tumor control after resection bed radiosurgery of brain metastases. Neurosurgery 73(6):1001\u20131006. https:\/\/doi.org\/10.1227\/NEU.0000000000000148","journal-title":"Neurosurgery"},{"issue":"Suppl","key":"10379_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3171\/2014.6.GKS14708","volume":"121","author":"E Ojerholm","year":"2014","unstructured":"Ojerholm E, Lee JY, Thawani JP et al (2014) Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. J Neurosurg 121(Suppl):75\u201383. https:\/\/doi.org\/10.3171\/2014.6.GKS14708","journal-title":"J Neurosurg"},{"issue":"12","key":"10379_CR38","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/0284186X.2019.1643917","volume":"58","author":"S Scharl","year":"2019","unstructured":"Scharl S, Kirstein A, Kessel KA et al (2019) Stereotactic irradiation of the resection cavity after surgical resection of brain metastases - when is the right timing? Acta Oncol 58(12):1714\u20131719. https:\/\/doi.org\/10.1080\/0284186X.2019.1643917","journal-title":"Acta Oncol"},{"issue":"2","key":"10379_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10585-025-10334-5","volume":"42","author":"L Kretzschmar","year":"2025","unstructured":"Kretzschmar L, Gabrys H, Joye A, Kraft J, Guckenberger M, Andratschke N (2025) Postoperative stereotactic radiosurgery (SRS) vs hypofractionated stereotactic radiotherapy (SRT) for resected brain metastases - a single centre analysis. Clin Exp Metastasis 42(2):16. https:\/\/doi.org\/10.1007\/s10585-025-10334-5","journal-title":"Clin Exp Metastasis"},{"issue":"Suppl","key":"10379_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3171\/2014.7.GKS141488","volume":"121","author":"C Iorio-Morin","year":"2014","unstructured":"Iorio-Morin C, Masson-C\u00f4t\u00e9 L, Ezahr Y et al (2014) Early gamma knife stereotactic radiosurgery to the tumor bed of resected brain metastases for improved local control. J Neurosurg 121(Suppl):69\u201374. https:\/\/doi.org\/10.3171\/2014.7.GKS141488","journal-title":"J Neurosurg"},{"issue":"6","key":"10379_CR41","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3171\/2020.10.JNS201934","volume":"135","author":"DA Roth O\u2019Brien","year":"2021","unstructured":"Roth O\u2019Brien DA, Kaye SM, Poppas PJ et al (2021) Time to administration of stereotactic radiosurgery to the cavity after surgery for brain metastases: a real-world analysis. J Neurosurg 135(6):1695\u20131705. https:\/\/doi.org\/10.3171\/2020.10.JNS201934","journal-title":"J Neurosurg"},{"key":"10379_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clineuro.2016.01.008","volume":"142","author":"A Bilger","year":"2016","unstructured":"Bilger A, Milanovic D, Lorenz H et al (2016) Stereotactic fractionated radiotherapy of the resection cavity in patients with one to three brain metastases. Clin Neurol Neurosurg 142:81\u201386. https:\/\/doi.org\/10.1016\/j.clineuro.2016.01.008","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10379_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11060-015-1767-4","volume":"123","author":"BR Eaton","year":"2015","unstructured":"Eaton BR, LaRiviere MJ, Kim S et al (2015) Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases. J Neurooncol 123(1):103\u2013111. https:\/\/doi.org\/10.1007\/s11060-015-1767-4","journal-title":"J Neurooncol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-025-10379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-025-10379-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-025-10379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T04:21:45Z","timestamp":1764562905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-025-10379-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10379"],"URL":"https:\/\/doi.org\/10.1007\/s10585-025-10379-6","relation":{},"ISSN":["1573-7276"],"issn-type":[{"type":"electronic","value":"1573-7276"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research involves human participants with HKU\/HA HKW Institutional Review Board (HKU\/HA HKW IRB) approval. This study was performed in line with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"60"}}